Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Health Economics topic
No spam. Unsubscribe anytime.
Senate committee narrows AB 1415 to add private equity and MSO reporting to Office of Healthcare Affordability
Summary
AB 1415 was advanced by the Senate Committee on Health in amended form to require OCA to collect data from private equity, hedge funds and management‑services organizations involved in health‑care transactions; the bill’s amendments exclude health systems from cost‑targeting.
Get email alerts on the Health Economics topic
No spam. Unsubscribe anytime.
Assembly Bill 1415: The Senate Committee on Health considered AB 1415, a bill the author described as focused on affordability and transparency in health care. The amended measure removes health systems from cost‑targeting and instead gives the Office of Healthcare Affordability (OCA) authority to collect information from private equity, hedge funds and management‑services organizations (MSOs) involved in health‑care transactions so OCA can better assess impacts on cost and access.
Why it matters: The sponsor told the committee private‑equity acquisitions comprised roughly $4.31 billion of healthcare deals in California between 2019 and 2023 and argued private equity and MSOs can affect care, prices and access. Supporters said expanded reporting would give OCA better data to understand consolidation and its effect on affordability. Opponents—primarily hospitals and health systems—said the office had not yet demonstrated where existing authority was lacking, warned the change could delay distressed-provider transactions and recovery plans, and urged caution because federal funding and Medicaid uncertainties could further stress providers.
Testimony and concerns: Health‑access and labor advocates, the Attorney General’s office and AARP California supported the bill. Hospital systems and associations, academic medical centers and investment‑industry groups expressed concern or formal opposition, citing potential operational impacts, the need for more analysis, definitional clarity around MSOs and the risk of delaying transactions that might rescue distressed providers. The author and several committee members noted the bill’s amendments removed health systems from cost‑targeting and that expedited review processes exist for distressed hospitals.
Committee action and status: The committee moved AB 1415 as amended and referred it to the Committee on Appropriations. Senators discussed the importance of refining MSO definitions and avoiding delays for distressed providers; multiple senators indicated support contingent on continued work to clarify definitions and expedite reviews where needed. The hearing shows the committee’s presiding officer moved the bill and a roll-call indicated the measure was advanced; the final recorded vote in committee was 9 ayes, 2 noes.
Next steps: AB 1415 will be considered by the Senate Appropriations Committee; the author pledged to continue working with stakeholders on MSO definitions and procedural clarity before floor consideration.
